Raymond James Financial Inc. Sells 6,631 Shares of Bath & Body Works, Inc. $BBWI

Raymond James Financial Inc. lessened its position in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 1.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 676,649 shares of the company’s stock after selling 6,631 shares during the quarter. Raymond James Financial Inc. owned about 0.32% of Bath & Body Works worth $20,516,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the company. Fox Run Management L.L.C. raised its stake in shares of Bath & Body Works by 264.3% during the 1st quarter. Fox Run Management L.L.C. now owns 72,189 shares of the company’s stock worth $2,189,000 after acquiring an additional 52,372 shares in the last quarter. Boston Partners raised its stake in shares of Bath & Body Works by 289.7% during the 1st quarter. Boston Partners now owns 937,024 shares of the company’s stock worth $28,292,000 after acquiring an additional 696,555 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its stake in shares of Bath & Body Works by 9,569.1% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 11,893 shares of the company’s stock worth $361,000 after acquiring an additional 11,770 shares in the last quarter. GKV Capital Management Co. Inc. bought a new position in shares of Bath & Body Works during the 1st quarter worth approximately $69,000. Finally, Russell Investments Group Ltd. raised its stake in shares of Bath & Body Works by 10.8% during the 1st quarter. Russell Investments Group Ltd. now owns 191,916 shares of the company’s stock worth $5,819,000 after acquiring an additional 18,708 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Barclays reduced their price objective on shares of Bath & Body Works from $35.00 to $30.00 and set an “equal weight” rating for the company in a research note on Friday, May 30th. The Goldman Sachs Group cut their price target on shares of Bath & Body Works from $44.00 to $43.00 and set a “buy” rating on the stock in a research note on Friday, May 30th. Wells Fargo & Company upped their price target on shares of Bath & Body Works from $40.00 to $44.00 and gave the company an “overweight” rating in a research note on Wednesday, May 14th. Piper Sandler set a $39.00 price target on shares of Bath & Body Works and gave the company an “overweight” rating in a research note on Thursday, May 15th. Finally, UBS Group upped their price target on shares of Bath & Body Works from $32.00 to $36.00 and gave the company a “neutral” rating in a research note on Tuesday, May 20th. Fourteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $42.06.

Check Out Our Latest Stock Report on BBWI

Bath & Body Works Stock Performance

NYSE BBWI opened at $31.38 on Wednesday. The firm has a market capitalization of $6.64 billion, a P/E ratio of 8.37, a PEG ratio of 1.04 and a beta of 1.54. The stock has a 50-day simple moving average of $30.49 and a two-hundred day simple moving average of $30.90. Bath & Body Works, Inc. has a fifty-two week low of $24.94 and a fifty-two week high of $41.87.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its quarterly earnings data on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.02. The business had revenue of $1.40 billion during the quarter, compared to analysts’ expectations of $1.42 billion. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The company’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.38 EPS. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. As a group, analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Stockholders of record on Friday, August 22nd will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Friday, August 22nd. Bath & Body Works’s payout ratio is 21.33%.

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

See Also

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.